Cell Culture Market By Type 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Cell Culture Market
Cell Culture Market -By Type (Primary cell culture, Secondary cell culture) By Industry (Research Institutes, Biotechnology Companies, Pharmaceutical Companies) By Application (Bio Technology, Cancer Research, Tissue Culture & Others) -Forecast (2016-2021)
Report Code : HCR 0090
Published: 26 February, 2016   No. of pages: 144

  • Report Description
  • Table of Contents
  • Customization Options
Cell culture is one of the major tools used in cellular and molecular biology, delivering excellent model systems for studying the normal physiology and biochemistry of cells the effects of drugs and toxic compounds on the cells, and mutagenesis and carcinogenesis.  It is also used in drug screening and development, and large scale production of biological compounds.  The major advantage of using cell culture for any of these applications is the consistency and reproducibility of results that can be obtained from using a batch of clonal cells.

The global cell culture market is mainly categorized into products, type, application, end user and by geography. The key products of cell culture consumables are media, sera and reagent. 

The global cell culture market has grown significantly in the last ten years. The demand for artificial organs and biopharmaceuticals has boosted this market extensively in past and is likely to fuel its growth further in the coming years. Additionally, the rising usage of cell culture models in drug discoveries is expected to present an opportunity-rich market for major cell culture market players.

The global market for cell culture was assessed to be $xx bn in 2016. The cell culture market is projected to grow at a CAGR of xx% and is forecast to reach $xx bn by 2021. The 3D cell culture is forecast to have the maximum growth of xx% during the forecast period between 2016 and 2021. Cancer research laboratories and pharmaceutical companies are the major end-users for cell culture. North America and Europe alone are estimated to occupy a share of more than xx% during 2016-2021.

Cell Culture Market

Europe is the leading market for cell culture with Germany being the frontrunner. Europe region is forecast to have highest growth in the next few years due to growing adoption of cell culture in industrial applications. Europe cell culture market accounts to xx% of the global market for cell culture and is the fastest growing market followed by Americas. In Americas, Biopharmaceuticals and University research institutes are the major end users of cell culture.

The key players profiled in this report:
  • GE Healthcare
  • Asahi Breweries, Ltd.
  • Chugai Pharmaceutical Co.
  • Kyowa Hakko Kirin Co., Ltd.
  • Thermo Fisher Scientific
1. Market Overview
2. Executive Summary
3. Cell Culture  Market- Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End user Profiling
      3.2.3. Top 5 Financials Analysis
4. Cell Culture Market-Forces
   4.1. Market Drivers
   4.2. Market Constraints & Challenges
   4.3. Attractiveness of the Cell Culture Industry
      4.3.1. Power of Suppliers
      4.3.2. Threats From New Entrants
      4.3.3. Power of Buyer
      4.3.4. Threat From Substitute Product
      4.3.5. Degree of Competition
5. Cell Culture Market-Strategic Analysis
   5.1. Cell Culture Market - Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunity Analysis
   5.4. Product Life Cycle
   5.5. Suppliers and Distributors
   5.6. Regulation Analysis
6. Cell Culture Market By Type
   6.1. Introduction
   6.2. Primary  cell culture
   6.3. Secondary cell culture
   6.4. Monolayer  culture
   6.5. Others
7. Cell Culture Market By Application
   7.1. Introduction
   7.2. Biopharmaceuticals
   7.3. Cancer Research
   7.4. Tissue culture and Engineering
   7.5. Gene therapy
   7.6. Drug Screening & Development
   7.7. Others
8. Cell Culture Market By Product
   8.1. Introduction
   8.2. Basic Equipment
      8.2.1. Cell culture hood
      8.2.2. Incubator
      8.2.3. Water bath
      8.2.4. Centrifuge
      8.2.5. Refrigerator
      8.2.6. Cell counter
      8.2.7. Inverted microscope
      8.2.8. Sterilizer
      8.2.9. Others
   8.3. Expanded Equipment
      8.3.1. Aspiration pump
      8.3.2. pH meter
      8.3.3. Confocal microscope
      8.3.4. Flow cytometer
   8.4. Additional Supplies
      8.4.1. Pipettes
      8.4.2. Syringes and needles
      8.4.3. Waste containers
      8.4.4. Media, sera, and reagents
      8.4.5. Cell culture vessels
9. Cell Culture Market-By End User
   9.1. Introduction
   9.2. Research Institutes
   9.3. Bio technology Companies
   9.4. Pharmaceutical Companies
10. Cell Culture Market-By Geography
   10.1. Americas
      10.1.1. U.S.
      10.1.2. Canada
      10.1.3. Mexico
      10.1.4. Brazil
   10.2. Europe
      10.2.1. U.K.
      10.2.2. Germany
      10.2.3. Italy
   10.3. Asia
      10.3.1. China
      10.3.2. South Korea
      10.3.3. Japan
      10.3.4. India
   10.4. Rest of The World (ROW)
      10.4.1. Mea
      10.4.2. Oceania
11. Cell Culture Market-Entropy
   11.1. New Product Developments
   11.2. Mergers and Acquisitions
12. Company Profiles
   12.1. Thermo Fisher Scientific, Inc.
   12.2. Sanofi Biologics.
   12.3. LONZA Biologics
   12.4. GSK Biologicals
   12.5. GE Healthcare
   12.6. ETH Zurich.
   12.7. ProBioGen AG.
   12.8. Ajinomoto Co., Inc
   12.9. Asahi Breweries, Ltd.
   12.10. Asahi Kasei Pharma
   12.11. Astellas Pharma Inc
   12.12. Chugai Pharmaceutical Co.
   12.13. Cosmo Bio Co., Ltd.
   12.14. Dainippon Sumitomo Pharma Co., Ltd.
   12.15. Hitachi Plant Technologies, Ltd.
   12.16. JCR Pharmaceuticals Co., Ltd.
   12.17. Kyowa Hakko Kirin Co., Ltd.
   12.19. Thermo Fisher Scientific
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"

13. Appendix
   13.1. Abbreviations
   13.2. Sources
   13.3. Research Methodology
   13.4. Bibliography
   13.5. Compilation of Expert Insights
   13.6. Disclaimer
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports